[Peri-/Postoperative Anti-Inflammatory Therapy in Vitreoretinal Interventions]

Area of Science:

• Ophthalmology
• Retinal Surgery
• Pharmacology

Background:

• Perioperative anti-inflammatory drug use is standard in German ophthalmology for retinal surgery.
• Limited data exist on the specific efficacy of these treatments in vitreoretinal procedures.
• Current practices often extrapolate from anterior segment eye surgery data, which is more robust.

Purpose of the Study:

• To answer key clinical questions regarding the perioperative use of anti-inflammatory drugs in vitreoretinal surgery.
• To consolidate and present available study data on treatment efficacy.
• To provide evidence-based guidance for clinical practice.

Main Methods:

• Review of existing clinical literature and study data.
• Analysis of evidence pertaining to anti-inflammatory drug efficacy in vitreoretinal surgery.
• Comparison with established protocols for anterior segment surgery.

Main Results:

• Data on the efficacy of perioperative anti-inflammatory drugs in vitreoretinal surgery are scarce.
• Treatment protocols are often based on analogies to anterior segment surgery.
• Specific clinical questions are addressed with the best available evidence.

Conclusions:

• There is a need for more research into the efficacy of anti-inflammatory drugs in vitreoretinal surgery.
• Clinical decisions should be guided by available data, acknowledging current limitations.
• Standardizing treatment based on robust evidence is crucial for patient outcomes.